Attached files
| file | filename |
|---|---|
| EX-31.2 - RULE 13A-14(A) CERTIFICATION - HONGYUE HAO - AOXING PHARMACEUTICAL COMPANY, INC. | caxg10ka120090630ex31-2.htm |
| EX-31.1 - RULE 13A-14(A) CERTIFICATION - ZHENJIANG YUE - AOXING PHARMACEUTICAL COMPANY, INC. | caxg10ka120090630ex31-1.htm |
| 10-K/A - CHINA AOXING PHARMACEUTICAL CO., INC. FORM 10-K/A JUNE 30, 2009 - AOXING PHARMACEUTICAL COMPANY, INC. | caxg10ka120090630.htm |
EXHIBIT 32: Rule 13a-14(b)
Certification
The
undersigned officer certifies that this report fully complies with the
requirements of Section 13(a) of the Securities Exchange Act of 1934, and that
the information contained in the report fairly presents, in all material
respects, the financial condition and results of operations of China Aoxing
Pharmaceutical Company, Inc.
A signed
original of this written statement required by Section 906 has been provided to
China Aoxing Pharmaceutical Company, Inc. and will be retained by China Aoxing
Pharmaceutical Company, Inc. and furnished to the Securities and Exchange
Commission or its staff upon request.
|
March 16, 2010
|
/s/ Zhenjiang
Yue
|
|
|
Zhenjiang
Yue, Chief Executive Officer
|
|
March 16, 2010
|
/s/ Hui
Shao
|
|
|
Hui Shao , Chief
Financial Officer
|